Bio-FD&C Co

Bio-FD&C Co Diluted EPS

The Diluted Earnings per Share of Bio-FD&C Co (251120.KQ) as of Oct 21, 2026 is 781.60 KRW. In the previous year, Diluted Earnings per Share was 527.72 KRW — a change of 48.11% (higher).

Diluted EPS

781.60KRW

YoY

48.11%

Last updated:

Diluted Earnings per Share of Bio-FD&C Co is 2025 781.60 KRW. Diluted Earnings per Share of Bio-FD&C Co was 2024 527.72 KRW. It decreases by 48.11% higher compared to the previous year.

The Bio-FD&C Co Diluted EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Diluted EPS
Date
Diluted EPS
Jan 1, 2018
46.45 KRW
Jan 1, 2019
294.61 KRW
Jan 1, 2020
283.06 KRW
Jan 1, 2021
393.14 KRW
Jan 1, 2022
508.30 KRW
Jan 1, 2023
654.85 KRW
Jan 1, 2024
527.72 KRW
Jan 1, 2025
781.60 KRW
The Bio-FD&C Co Diluted EPS history
YEARDiluted EPSYoY
781.60KRW+48.11%
527.72KRW-19.41%
654.85KRW+28.83%
508.30KRW+29.29%
393.14KRW+38.89%
283.06KRW-3.92%
294.61KRW+534.28%
46.45KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Bio-FD&C Co Stock analysis

What does Bio-FD&C Co do? Bio-FD&C Co., Ltd. develops bio and health technologies, focusing on manufacturing and selling soybean callus culture extract, clock stem cell, centella asiatica, callus extract, aloe barbadensis phytoplaceta extract, prunus mume phytoplacenta extract, secale cereale adventitious root extract, and acanthopanax koreanum adventitious root culture extract. These products serve as key materials for cosmeceuticals, health functional foods, and pharmaceuticals, targeting companies in the cosmetics, health supplement, and pharmaceutical industries. The company generates revenue through direct sales of these specialized extracts to manufacturers who incorporate them into their final products. The firm's product portfolio includes unique bioactive compounds like centella asiatica and prunus mume phytoplacenta extract, which are used in high-value applications within the cosmeceutical and pharmaceutical sectors. By supplying these specialized ingredients, Bio-FD&C Co., Ltd. caters to clients seeking natural, plant-based solutions for product development. Its focus on extract-based materials positions it as a supplier for companies developing innovative health and beauty products. Bio-FD&C Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bio-FD&C Co stock

Diluted Earnings per Share of Bio-FD&C Co is 781.60 KRW in 2025.

Diluted Earnings per Share of Bio-FD&C Co changed from 527.72 KRW to 781.60 KRW, representing a 48.11% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Diluted Earnings per Share Bio-FD&C Co since 2006 – with annual values, charts, and detailed analysis.

Diluted EPS accounts for all potential shares from options, warrants, and convertible securities. It provides a more conservative per-share earnings measure.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Bio-FD&C Co

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Bio-FD&C Co